59th Annual AES Meeting

WASHINGTON, Dec. 2 /PRNewswire/ --

  WHO:   You are invited to join leading medical and scientific experts at
         the largest epilepsy-related conference in the nation as they
         explore new research in the diagnosis, treatment and scientific
         understanding of epilepsy, a disorder that affects approximately
         100 million people worldwide.

  WHAT:  The American Epilepsy Society's 59th Annual Meeting

  WHERE: Washington Convention Center
         801 Mount Vernon Place, N.W., Washington, DC
         Press room is located at the convention center in room #305

  WHEN:  Meeting: Friday, December 2nd to Tuesday, December 6th, 2005

         Platform Presentations:
         Monday, December 5th, 3:00 p.m.- 6:00 p.m.

         Poster Sessions:
         Sunday, December 4th, noon-5:00p.m
         Monday, December 5th, 8:00 a.m. to 5:00 p.m.
         Tuesday, December 6th, 8:00 a.m. to 1:00 p.m.

         Press Room Hours:
         Friday, December 2nd, 2:00 p.m.- 7:30 p.m.
         Saturday, December 3rd, 8:00 a.m.- 6:00 p.m.
         Sunday, December 4th, 8:00 a.m.- 6:00 p.m.
         Monday, December 5th, 8:00 a.m.- 6:00 p.m.
         Tuesday, December 6th, 8:00 a.m.- 5:00 p.m.

  WHY:   Find out the latest data on epilepsy, the most common neurological
         disorder of the brain including:

         * How do treatments impact psychiatric and behavioral adverse
           events in pediatric patients?

         * What treatments are effective for elderly patients diagnosed with
           epilepsy?

         * Beyond pharmacotherapy; what alternative treatments are available
           to improve a patient's quality of life?

Contact Christer Osterling at 850.586.7500 / costerling@aesnet.org or Lindsey Smith at 212.229.8481 or lsmith@aesnet.org to:

  * Register
  * Obtain advance materials or abstracts
  * Arrange interviews with researchers and physicians


                           Sunday, December 4th
                     Poster Sessions: noon - 5:00p.m.

  Highlights from today's meeting include data on the following topics:

  Epilepsy and Women
  * Twelve year interim results from an international observational study of
    pregnancy outcomes following (Poster #212)
  * Five Year Data from the Australian Pregnancy Registry for Women on
    Antiepileptic Medication (Poster #219)
  * Antiepileptic Drug Use and Birth Rate in Patients with Epilepsy (Poster
    #207)


                           Monday, December 5th
               Platform Presentations: 3:00p.m. - 6:00 p.m.
                  Poster Sessions: 8:00 a.m. - 5:00 p.m.

  Highlights from today's meeting include data on the following topics:

  Pediatrics
  * Evaluation of the Relative Risk of Psychiatric and Behavioral Adverse
    Events in Pediatric Patients with Refractory Partial Seizures Treated
    with levetiracetam -- Impact of Prior History and a Comparison with
    Adult Data (Poster # 2.338a)
  * Seizure-Free Rate in Patients with Partial Seizures Receiving
    Oxcarbazepine Monotherapy: A Pooled Analysis (Poster #365)
  * Seizure Control with Levetiracetam in Juvenile Myoclonic Epilepsies
    (Poster #339)
  * Effect of in utero exposure to anti-epileptic medication on the
    cognitive abilities of school age children  (Platform Series A.02)
  * Epilepsy. Use of Second Generation AntiEpileptic Drugs and Association
    of Behavioral and Psychiatric Events in Children (Poster #303)
  * Use of Levetiracetam in Juvenile Myoclonic Epilepsy (Poster #333)
  * Clobazam for the Treatment of Intractable Childhood Epilepsy  (Poster
    #332)

  Epilepsy and the Elderly
  * An International Multicenter Double-Blind Randomized Comparative Trial
    of Lamotrigine and Slow Release Carbamazepine in Elderly Patients with
    Newly Diagnosed Epilepsy  (Poster #372)

  Vagal Nerve Stimulation
  * Long Term VNS Experience in Normal and Mentally Retarded Adults and
    Children(Poster #413)

  Implants
  * Safety and evidence for efficacy of an implantable responsive
    neurostimulator (RNS(R)) for the treatment of medically intractable
    partial onset epilepsy in adults  (Poster #397)

  Alternative Treatments
  * A Modified Atkins Diet is Effective for the Treatment of Intractable
    Pediatric Epilepsy: Results from a Prospective Trial (Platform Series
    A.01)
  * Beneficial Effects on Sleep of Ketogenic Diet in Children with Therapy
    Resistant Epilepsy  (Poster #404)

  Health Economics
  * Cost-effectiveness of epilepsy surgery in a cohort of patients with
    medically intractable epilepsy: How many years to divide out
    pre-surgical explorations and surgery costs? (Poster #450)

  Concomitant Conditions
  * Carbamazepine May Induce Osteoporosis by Increasing Bone Turnover in
    Postmenopausal Women (Poster #260)
  * Children Treated for Epilepsy Have Significant Reduction in Bone Mineral
    Density (Poster #211)
  * Double-Blind Evaluation of the Cognitive Effects of Lamotrigine Versus
    Topiramate Adjunctive Therapy (Poster #225)

  Adjunct Treatment Options
  * A Double-Blind, Placebo-Controlled Evaluation of Lamotrigine for Obesity
    (Poster #267)
  * Pregabalin as Add-On Treatment for Partial Seizures With or Without
    Secondary Generalizations: Efficacy, Safety, and Tolerability Findings
    from the Analysis of Four Randomized Clinical Trials (Poster #219)

  Idiopathic and Localization Related Epilepsy
  * Prospective outcome of Levetiracetam efficacy in refractory idiopathic
    generalized and localization related epilepsy in adults (Poster #266)


                          Tuesday, December 6th
                  Poster Sessions: 8:00 a.m. - 1:00 p.m.

  Highlights from today's meeting include data on the following topics:

  Epilepsy and Women
  * Distribution of Seizures During the Menstrual Cycle in Women with
    Epilepsy (Poster #190)

  Epilepsy in the Elderly
  * Epilepsy in Seniors: Knowledge and Practice Patterns among 221 Health
    Care Providers: An Epilepsy Foundation Study (Poster #258)

  Alternative Treatments
  * A Controlled Clinical Trial of Direct Current Stimulation in Patients
    with Refractory Epilepsy (Poster #157)

To obtain copies of full abstracts contact Christer Osterling at 850.586.7500 / costerling@aesnet.org or Lindsey Smith at 212.229.8481/ lsmith@aesnet.org